Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease (Q40840258)

24 September 2017

1 reference

title

Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease (English)

1 reference

24 September 2017

1 reference

Lewis SJ

1 reference

24 September 2017

Freedman AR

series ordinal

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

Alimentary Pharmacology & Therapeutics

24 September 2017

published in

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

807-822

1 reference

"Probiotic" remedies are not what they seem

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Probiotics in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Antimicrobial substance from a human Lactobacillus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Impact of Bifidobacterium longum on human fecal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Enteral feeding of premature infants with Lactobacillus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive effects of dietary lactulose and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Effects of lactulose and lactitol on colonic microflora and enzymatic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Disposition kinetics of Saccharomyces boulardii in man and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Uptake of yeast (Saccharomyces boulardii) in normal and rotavirus treated intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

The role of lactic acid bacteria in colon cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Controlled trial of orally administered lactobacilli in acute infantile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Nosocomial acquisition of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Impact of antimicrobial agents on human intestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Relapse versus reinfection withClostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Erythromycin induces migrating motor complex in human gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Lactobacillus Bacteremia and Endocarditis: Review of 45 Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Fever of unknown origin secondary to brewer's yeast ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Brewer's yeast as a cause of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00386.X

10.1046/J.1365-2036.1998.00386.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference